News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology
description
Transcript of News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology
![Page 1: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/1.jpg)
News on an old problemNephrology view
Dr. Oğuz Söylemezoğlu
Gazi University Pediatric NephrologyAnkara,Turkey
Challenging issues about vasculitis
![Page 2: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/2.jpg)
Vasculitis
Inflammation and damage to vessel wall
Independent of size or vessel type
Localized vs. systemic disease
Diverse symptoms and overlap
Difficult classification
![Page 3: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/3.jpg)
Pathophysiology of Vasculitis
Pathogenic immune complex formation and/or deposition
Pathogenic T-lymphocyte responses and granuloma formation
Non-endothelial structures of the vessel wall are involved in controlling the inflammatory process, eg acting as antigen presenting cells and contributing pro-inflammatory mediators.
Pathogenetic role of ANCA ??
![Page 4: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/4.jpg)
Eular/Pres Ozen, Dillon et alDedeoglu,Sundel . Rheum Dis P Clin N Am2007
2006
![Page 5: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/5.jpg)
![Page 6: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/6.jpg)
Turkish survey of paediatric vasculitis (Vasculitis study group. Clin Rheum 2007)
![Page 7: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/7.jpg)
![Page 8: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/8.jpg)
![Page 9: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/9.jpg)
Overview : ANCA Associated VasculitisWhat are the challenges
Non toxic effective treatments Earlier diagnosis at 1st presentation and relapse Animal models
A move towards designer biologic therapies Targeting B cells Targeting T cells
![Page 10: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/10.jpg)
![Page 11: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/11.jpg)
![Page 12: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/12.jpg)
![Page 13: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/13.jpg)
The stages of the management of the disease
![Page 14: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/14.jpg)
Very few studies in childhood
![Page 15: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/15.jpg)
Wegener’s Granulomatosis
General necrotizing granulomas of upper airway, lower airway,
kidney bilateral pneumonitis 95% chonic sinusitis 90% mucosal ulceration of nasopharynx 75% renal disease 50-80% hallmark pathologic lesion
necrotizing granulomatous vasculitis
![Page 16: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/16.jpg)
![Page 17: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/17.jpg)
![Page 18: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/18.jpg)
![Page 19: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/19.jpg)
![Page 20: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/20.jpg)
![Page 21: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/21.jpg)
![Page 22: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/22.jpg)
![Page 23: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/23.jpg)
![Page 24: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/24.jpg)
IV pulse vs daily oral Cyclophosphamide ??
![Page 25: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/25.jpg)
![Page 26: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/26.jpg)
![Page 27: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/27.jpg)
![Page 28: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/28.jpg)
Leflunomide Remission maintenance in WG
Infliximab and etanercept (TNF blockade) WGET (70% remission , high rate relaps ) Infliximab induced 88% remission
IVIG Antithymocyte Globulin
SOLUTION study in refractory WG
Deoxyspergualin Blocks the Transcriptional activation of L chain expression B Cell Blocks the development of cytotoxic T cells Trials underway
Strategies to reduce relapses ??How to treat resistant disese ??
![Page 29: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/29.jpg)
![Page 30: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/30.jpg)
Blocking B lyS
Campath 1(Alemtuzumab) anti-CD 52 Belimumab (Lymphostat-B)
In phase lll clinical trials in SLE
Atacicept:TACI Bloker(Phase ll)
BR3-Fc: BAFF Bloker
![Page 31: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/31.jpg)
Rituximab
Part mouse , part human
Originallyused for lymphcancer ,RA
Knocks outB cells
Usually given 2 injections,2w apart
![Page 32: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/32.jpg)
![Page 33: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/33.jpg)
![Page 34: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/34.jpg)
![Page 35: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/35.jpg)
![Page 36: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/36.jpg)
![Page 37: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/37.jpg)
Abatacept (Orencia)
Only targets T cells that are activated to cause damage and makes them ‘anergic’
Potential to be highly selective therapy Currently undergoing phase lll therapy
ABAVAS (BMS)
![Page 38: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/38.jpg)
![Page 39: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/39.jpg)
![Page 40: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/40.jpg)
Chan AT,Autoimmunity Rev. 2006
![Page 41: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/41.jpg)
Hypothetical events in the pathogenesis of ANCA small vessel vasculitis
Jennette JC,Falk RJ. Curr Op Rheum 2008
![Page 42: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/42.jpg)
Microscopic polyangiitis: the future
Differences between MPA and WG The role of respiratory epithelium in the induction
ANCA –negative vasculitis and vasculitis affecting different sizes of vessels
Molecular approches to classification will address
Therapeutics will have reduced steroids Newer targets :Improve the speed and quality of remission
intracellular regulators of cytokines Complement components Antioxidants (N –acetyl cysteine
![Page 43: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/43.jpg)
![Page 44: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/44.jpg)
BEHCET’S DISEASE
![Page 45: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/45.jpg)
Behcet’s DiseaseVasculitis with triad
oral, genital ulcers,
uveitis or iritis
![Page 46: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/46.jpg)
Renal Involvement in BD ?
The frequency of renal problems vary between 0% to 55%. Amyloidosis glomerulonephritis renal vascular disease, interstitial nephritis
Akpolat .T et al Semin Arthritis Rheum. 2008
![Page 47: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/47.jpg)
What are the news in BD? TNF--1031 C allele was associated with disease susceptibility
Akman A,et al Br J Dermatol 2006
T helper type 1 immune reaction in active disease
Yanagihori et alJ Invest Dermatol,2006
IL-12 B heterozygocity is associated with BD E-NOS gene polymorphism (Glu 298Asp) associated with BD
Oksel et al. Clin Exp Rheumatol 2006
IL-18 levels were high in BD and correlated with activity Musabak et al, Rheumatol Int 2006
Anti-SBP(Sleneium Binding protein) positive with uveitis Okunuki et al Exp Eye Res 2007
Therapy Anti-TNF agents Topical G-CSF for ulcers Granulocytopheresis for refractory uveoretinitis
![Page 48: News on an old problem Nephrology view Dr. Oğuz Söylemezoğlu Gazi University Pediatric Nephrology](https://reader036.fdocuments.us/reader036/viewer/2022081506/56814579550346895db24ac9/html5/thumbnails/48.jpg)
Conclusions Childhood forms of vasculitis are in similar
spectrum to adult disease Long term treatment is similar Emphasis on KD,HSP less WG and MPA Large controlled trials of infliximab and rituximab
are required Therapy still depends on conventional drugs Effects of disease and treatment on growth and
development need to be addressed in children